When creating a new medical device to the market, there’s much more that goes into designing, developing and introducing it to the market. To be able to enter the certain markets, the development and...
Recent Posts
Danish company Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions.
“At Innokas Medical, everything begins with the quality built into our processes, products and services. The most important know-how as well as the high standards of our daily operations can be seen...
Medical devices have remarkably important role in patient care. The key element in the sector is that there cannot be any compromises done with the safety and effectiveness of the devices – the...
The objective of Finnish healthcare technology company Lymphatouch’s negative pressure treatment is to improve patients’ quality of life by reducing pain and tissue swelling. Innokas Medical is...
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, has now reached a significant milestone as the device has received CE mark and the sales has started. The...
Innokas Medical has entered into manufacturing collaboration with Swedish medical technology company ScandiDos AB. This collaboration brings yet another Swedish customer to Innokas, providing...
New Product Introduction (NPI) and Design Transfer are both important parts of the whole life cycle of medical product from idea to market launch. Successful prototype series and professional...
Swedish health tech innovator Coala Life AB selected Innokas Medical to manufacture Coala Heart Monitor, which has global market potential.
